News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,219 Results
Type
Article (13658)
Company Profile (100)
Press Release (249461)
Section
Business (88009)
Career Advice (464)
Deals (15338)
Drug Delivery (64)
Drug Development (36580)
Employer Resources (49)
FDA (6273)
Job Trends (6191)
News (150161)
Policy (14026)
Tag
Academia (437)
Alliances (23190)
Alzheimer's disease (373)
Approvals (6283)
Artificial intelligence (79)
Bankruptcy (144)
Best Places to Work (4361)
Breast cancer (66)
Cancer (464)
Cardiovascular disease (48)
Career advice (406)
Cell therapy (63)
Clinical research (30675)
Collaboration (247)
Compensation (97)
COVID-19 (752)
C-suite (79)
Data (457)
Diabetes (64)
Diagnostics (1261)
Drug discovery (45)
Drug pricing (59)
Earnings (31660)
Events (37063)
Executive appointments (279)
FDA (6547)
Funding (157)
Gene therapy (73)
GLP-1 (315)
Government (1275)
Healthcare (3558)
Infectious disease (774)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5856)
Job creations (2050)
Job search strategy (372)
Layoffs (171)
Legal (3422)
Lung cancer (65)
Manufacturing (115)
Medical device (1271)
Medtech (1273)
Mergers & acquisitions (9593)
Metabolic disorders (200)
Neuroscience (502)
NextGen: Class of 2025 (1581)
Non-profit (592)
Northern California (562)
Obesity (119)
Opinion (113)
Patents (71)
People (28680)
Pharmaceutical (63)
Phase I (7991)
Phase II (12966)
Phase III (11647)
Pipeline (236)
Policy (48)
Postmarket research (1402)
Preclinical (3184)
Radiopharmaceuticals (118)
Rare diseases (121)
Real estate (2634)
Regulatory (9946)
Research institute (564)
Resumes & cover letters (55)
Southern California (547)
Startups (1626)
United States (5473)
Vaccines (124)
Weight loss (86)
Date
Today (45)
Last 7 days (228)
Last 30 days (914)
Last 365 days (12400)
2025 (908)
2024 (12512)
2023 (14256)
2022 (19564)
2021 (20083)
2020 (19048)
2019 (14905)
2018 (11730)
2017 (13911)
2016 (13135)
2015 (15479)
2014 (12428)
2013 (10599)
2012 (11397)
2011 (11924)
2010 (10891)
Location
Africa (313)
Arizona (46)
Asia (19954)
Australia (2583)
California (1318)
Canada (734)
China (172)
Colorado (52)
Connecticut (54)
Europe (39064)
Florida (226)
Illinois (148)
Indiana (106)
Japan (61)
Kansas (53)
Maryland (195)
Massachusetts (1130)
Minnesota (72)
New Jersey (548)
New York (370)
North Carolina (320)
Northern California (562)
Pennsylvania (339)
South America (500)
Southern California (547)
Texas (171)
Virginia (51)
Washington State (86)
263,219 Results for "jcr pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025
January 28, 2025
·
8 min read
Press Releases
JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy
January 6, 2025
·
5 min read
Press Releases
JCR Pharmaceuticals Initiates Phase III Clinical Trial of JR-142 in Japan, a Long-Acting Growth Hormone Therapy
December 23, 2024
·
3 min read
Business
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
JCR Pharmaceuticals Co., Ltd. announced today that Takeda Pharmaceutical Co., Ltd. (“Takeda”) decided to discontinue their collaboration with JCR to develop gene therapies using adeno-associated viruses (AAV) combined with the JCR J-Brain Cargo ® Technology.
December 21, 2023
·
4 min read
Press Releases
JCR Pharmaceuticals Initiates First Dosing in Phase I Clinical Trial of JR-441 for Mucopolysaccharidosis Type IIIA
October 31, 2024
·
4 min read
Business
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo ® Technology for Neurodegenerative Disease in Research Collaboration with Alexion.
March 19, 2024
·
4 min read
Press Releases
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Announce Initiation of First Dosing in Phase I/II Clinical Trial of JR-446 for Mucopolysaccharidosis Type IIIB in Japan
December 6, 2024
·
5 min read
News
JCR Pharmaceuticals to Present at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Congress
October 16, 2024
·
2 min read
Genetown
Modalis and JCR Pharmaceuticals enter into joint research agreement
Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) today announced that it has entered into a joint research agreement with JCR Pharmaceuticals Co., Ltd. (JCR Pharmaceuticals) on joint evaluation of the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target.
December 12, 2023
·
2 min read
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
JCR Pharmaceuticals Co., Ltd. announced today that it will present six presentations at the 20th Annual WORLD Symposium ™ 2024, to be held February 4-9, 2024 in San Diego, Calif.
January 25, 2024
·
13 min read
1 of 26,322
Next
